Cadila Healthcare gains on announcing a collaborative program with the National Institute of Allergy and Infectious Diseases

23 Apr 2015 Evaluate

Cadila Healthcare is currently trading at Rs. 1755.80, up by 7.35 points or 0.42 % from its previous closing of Rs. 1748.45 on the BSE.

The scrip opened at Rs. 1770.00 and has touched a high and low of Rs. 1770.00 and Rs. 1742.20 respectively. So far 864 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1998.00 on 07-Apr-2015 and a 52 week low of Rs. 872.55 on 19-May-2014.

Last one week high and low of the scrip stood at Rs. 1824.55 and Rs. 1700.00 respectively. The current market cap of the company is Rs. 35987.62 crore.

The promoters holding in the company stood at 74.79 % while Institutions and Non-Institutions held 14.72 % and 10.48 % respectively.

Zydus’ Vaccine R & D subsidiary -- Etna Biotech -- announced a collaborative program with the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health- for advancing leishmaniasis research. Under a separate gift agreement, Etna Biotech also extended its support of the NIH leishmaniasis program by donating $240,000 for research.

The program’s goal is to collaborate NIAID's Vector Molecular Biology Section and Etna Biotech, the Vaccine Research Center of Zydus in Italy, to investigate the importance of vector salivary proteins in a future leishmaniasis vaccine, and testing in natural models of parasite transmission a combination of Leishmania antigens with a sand fly salivary protein to develop a novel candidate vaccine against visceral leishmaniasis (VL).

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. It is the only Indian pharma company to launch its own patented NCE - Lipaglyn, the world’s first drug to be approved for the treatment of diabetic dyslipidemia.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×